Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year earnings per share growth rate
Percentile
P18
Within normal range
vs 3Y Ago
-8.4x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -64.44% |
| Q2 2025 | -150.00% |
| Q1 2025 | -350.35% |
| Q4 2024 | 147.93% |
| Q3 2024 | 62.50% |
| Q2 2024 | 42.03% |
| Q1 2024 | -25.45% |
| Q4 2023 | 36.05% |
| Q3 2023 | -774.87% |
| Q2 2023 | 75.42% |
| Q1 2023 | -37.93% |
| Q4 2022 | -20.83% |
| Q3 2022 | 7.69% |
| Q2 2022 | 13.33% |
| Q1 2022 | -20.00% |
| Q4 2021 | -13.64% |
| Q3 2021 | 12.00% |
| Q2 2021 | 7.41% |
| Q1 2021 | 32.50% |
| Q4 2020 | -29.03% |
| Q3 2020 | -19.23% |
| Q2 2020 | 46.94% |
| Q1 2020 | -2.08% |
| Q4 2019 | 34.25% |
| Q3 2019 | -30.36% |
| Q2 2019 | 30.00% |
| Q1 2019 | 74.92% |
| Q4 2018 | -151.18% |
| Q3 2018 | 50.97% |
| Q2 2018 | 21.52% |
| Q1 2018 | 36.05% |
| Q4 2017 | -319.51% |
| Q3 2017 | 92.72% |
| Q2 2017 | 37.78% |
| Q1 2017 | 72.29% |
| Q4 2016 | -116.72% |
| Q3 2016 | 55.51% |
| Q2 2016 | 11.68% |
| Q1 2016 | -99.38% |
| Q4 2015 | -37.43% |